Editor: The most recent election showcased that Pennsylvania’s elections are free, fair and secure. Since no excuse mail-in voting began in Pennsylvania, election officials have made it a ...

There are no studies documenting the percentage of doctors taking the drugs. But physicians “are a good litmus test for drugs that are highly effective,” Dr. Califf said. If doctors who read the ...

Pennsylvania, get our legislation in place! Karen Overly Smith, Upper Allen Township, Pa. If you purchase a product or register for an account through a link on our site, we may receive compensation.

Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said on Wednesday its net profit jumped 21 per cent in 2024 to 100 billion Danish ...

The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower growth this year. By Eshe Nelson Reporting from London Novo Nordisk ...

Ozempic and Wegovy has been prescribed to Yorkshire patients hundreds of times in the past year - and it's not for weightloss. According to data from the NHS' Open Prescribing service, semaglutide ...

Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and Wegovy develop complications with their eyesight, highlighting that we ...

However, it contains the same active ingredient — semaglutide — as Ozempic and Wegovy. Ozempic and Wegovy are FDA-approved, and studies show they’re effective for weight loss. The long version?

The maker of blockbuster weight-loss drugs Ozempic and Wegovy reported fourth-quarter sales jumped 30% year-over-year to 85.68 billion Danish kroner ($11.97 billion), above the DKK80.62 billion ...

A breakthrough in weight loss medication is on the horizon. While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more convenient ...